Nanobiotix Ownership | Who Owns Nanobiotix?
Nanobiotix Ownership Summary
Nanobiotix is owned by 0.01% institutional investors, and 99.99% retail investors. Johnson & johnson is the largest institutional shareholder, holding 11.86% of NBTX shares. Baillie Gifford Global Discovery A Acc is the top mutual fund, with 3.24% of its assets in Nanobiotix shares.
NBTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nanobiotix | 0.01% | - | 99.99% |
| Sector | Healthcare Stocks | 42.64% | 10.86% | 46.50% |
| Industry | Biotech Stocks | 45.45% | 10.77% | 43.78% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Johnson & johnson | 5.62M | 11.86% | $106.23M |
| Blackrock | 239.01K | 0.65% | $1.20M |
| Optiver b.v. | 5.36K | 0.01% | $101.17K |
| Morgan stanley | 2.38K | 0.01% | $44.92K |
| Ubs group | 1.53K | 0.00% | $35.37K |
| Bank of america corp /de/ | 760.00 | 0.00% | $3.80K |
| Eversource wealth advisors | 514.00 | 0.00% | $9.71K |
| Bnp paribas arbitrage, snc | 400.00 | 0.00% | $7.56K |
| Gamma investing | 229.00 | 0.00% | $5.29K |
| Royal bank of canada | 125.00 | 0.00% | $2.00K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Johnson & johnson | 5.62M | 21.09% | $106.23M |
| Eversource wealth advisors | 514.00 | 0.00% | $9.71K |
| Gamma investing | 229.00 | 0.00% | $5.29K |
| National bank of canada /fi/ | 13.00 | - | $245.00 |
| Tower research capital llc (trc) | - | - | - |
| Blackrock | 239.01K | - | $1.20M |
| Optiver b.v. | 5.36K | - | $101.17K |
| Barclays | 4.00 | - | $76.00 |
| Bank of america corp /de/ | 760.00 | - | $3.80K |
| Baillie gifford | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Optiver b.v. | 5.36K | - | 5.36K |
| Bank of america corp /de/ | 760.00 | - | 498.00 |
| Gamma investing | 229.00 | 0.00% | 229.00 |
| Barclays | 4.00 | - | 4.00 |
| National bank of canada /fi/ | 13.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baillie gifford | - | - | -2.87M |
| Perceptive advisors | - | - | -105.05K |
| Blackrock funding, inc. /de | - | - | -51.48K |
| Old mission capital | - | - | -48.47K |
| Blackrock | 239.01K | - | -14.45K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Optiver b.v. | 5.36K | - | 5.36K | $101.17K |
| Gamma investing | 229.00 | 0.00% | 229.00 | $5.29K |
| Barclays | 4.00 | - | 4.00 | $76.00 |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -241.00 |
| Jpmorgan chase | -256.00 |
| Qube research | -343.00 |
| Tower research capital llc (trc) | -7.92K |
| Geode capital management | -10.18K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 3 | -66.67% | 5,903 | -99.90% | - | 0.01% | 1 | -80.00% | 1 | - |
| Jun 30, 2025 | 9 | -10.00% | 5,645,167 | -2.01% | 11 | 8.04% | 5 | 150.00% | 1 | -75.00% |
| Mar 31, 2025 | 10 | -37.50% | 5,761,181 | -5.04% | 12 | 7.35% | 2 | -80.00% | 4 | - |
| Dec 31, 2024 | 16 | 60.00% | 6,067,225 | -5.47% | 12 | 6.94% | 10 | 233.33% | 4 | 300.00% |
| Sep 30, 2024 | 10 | -16.67% | 6,418,032 | -30.94% | 13 | 3.50% | 3 | -25.00% | 1 | -50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Baillie Gifford Global Discovery A Acc | 1.54M | 3.24% | 8.29K |
| Edinburgh Worldwide Ord | 1.34M | 2.83% | - |
| iShares Biotechnology ETF | 51.48K | 0.11% | -128.00 |
| Fidelity Nasdaq Composite Index | 10.18K | 0.02% | - |
NBTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools